SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4.77 |
| Enterprise Value ($M) | 4.94 |
| Book Value ($M) | 1.19 |
| Book Value / Share | 0.04 |
| Price / Book | 4.02 |
| NCAV ($M) | -1.11 |
| NCAV / Share | -0.04 |
| Price / NCAV | -4.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.31 |
| Return on Assets (ROA) | -2.80 |
| Return on Equity (ROE) | -10.76 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.13 |
| Current Ratio | 0.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.16 |
| Assets | 2.46 |
| Liabilities | 1.27 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -5.54 |
| Net Income | -6.15 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -2.95 |
| Cash from Investing | -0.12 |
| Cash from Financing | 3.13 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 12,655 | 26,243 | 48.22 | |
| 4,482 | 59,200 | 7.57 | |
| 1,726 | 70,709 | 2.44 | |
| 10,672 | 69,779 | 15.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IXHL – Incannex Healthcare Inc. | JANX – Janux Therapeutics, Inc. |
| KALV – KalVista Pharmaceuticals, Inc. | KOD – Kodiak Sciences Inc. |
| KROS – Keros Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io